Preoperative differentiation between responders and non-responders to ventriculoperitoneal (VP) shunting in the treatment of normal pressure hydrocephalus (NPH) remains a significant challenge. Identifying biomarkers in presurgical assessment represents a promising approach to reducing the need for invasive cerebrospinal fluid CSF testing. In this prospective observational study, thirty adult patients were classified into Group A (responders to VP shunting) and Group B (non-responders) based on their responsiveness to invasive CSF testing. The overall clinical condition and Idiopathic NPH (iNPH) scale were assessed at baseline. Additionally, biomarker levels were compared between the two groups. Elevated levels of Neurofilament Light Chain (NfL) and Neurofilament Heavy Chain (NfH) in CSF and a reduced level of beta-amyloid Aβ42 were observed. No significant differences in biomarker levels were found between groups. Individual biomarkers demonstrated only poor predictive value (AUC = 0.37–0.53). Clinical factors were stronger predictors (AUC = 0.642–0.669), with no improvement when combined with all examined biomarkers (AUC = 0.428–0.431). No single biomarker reliably predicted confirmed postoperative shunt responsiveness among patients who underwent VP shunt placement and demonstrated clinical improvement. Clinical factors were stronger predictors, suggesting that patient history and clinical assessment (e.g., the iNPH scale) provide more reliable diagnostic information. Notably, combining biomarkers with clinical factors did not improve predictive accuracy.
Purpose: To evaluate whether nanofibrous anti-adhesion membranes reduce epidural scar formation after lumbar laminectomy in a rabbit two-level model, comparing a non-degradable PVDF membrane with a degradable PCL membrane. Methods: Adult rabbits underwent L1 laminectomy (internal control) and L5 laminectomy with membrane implantation (PVDF or PCL). The primary endpoint was epidural scar width (mean and maximum) on histology in paired within-animal comparisons (L5 vs. L1). For PVDF, we used a one-sided paired Wilcoxon test (α = 0.05); effect sizes are reported as Hodges–Lehmann median paired difference with 95% CI. The PCL group (small n) was analysed descriptively. Results: PVDF implantation yielded consistently narrower scars than the paired internal control, reaching statistical significance (exact p = 0.016). The magnitude of reduction, although directionally favourable, did not meet the prespecified threshold for clinical relevance (≥ 90% narrowing). In the PCL group the material was largely resorbed by 12 weeks and was frequently associated with adhesive tissue bridges and neovascularization; due to the limited sample size, these findings are descriptive. Conclusions: A non-degradable PVDF nanofibrous membrane significantly reduced epidural scar width in a paired rabbit model but fell short of the predefined clinically meaningful reduction. Degradable PCL demonstrated rapid resorption with unfavourable adhesion morphology. These data support further optimization of membrane design and durability before clinical translation.
Background/Objectives neurofilament light chain (NfL) is a blood-accessible marker of neuroaxonal injury. We assessed the clinical utility of serum NfL in adults with idiopathic normal-pressure hydrocephalus (iNPH). Methods in a single-center prospective cohort (registered at ClinicalTrials.gov; partial overlap with a prior registry detailed in Supplementary Table S1), we enrolled 41 adults aged ≥ 50 years. The hydrocephalus arm included only anticipated ventriculoperitoneal (VP) shunt responders (Group A); non-hydrocephalus surgical patients served as controls (Group B). The primary analysis compared log-transformed serum NfL between groups using Welch’s t-test. A prespecified paired subset was sampled before premedication (baseline) and 24 h after surgery start. As a sensitivity analysis, we fitted age-aware linear models for log(NfL) with group as the exposure and age and sex as covariates. Results serum NfL was right-skewed; analyses used log-transformed values. The primary between-group contrast showed no difference (geometric mean ratio [GMR] 1.03; 95% CI 0.51–2.10; p = 0.93). In age-adjusted models (log[NfL] ~ group + age + sex), the between-group difference remained non-significant with an effect magnitude comparable to the unadjusted GMR. In paired analyses, serum NfL did not change from baseline to 24 h overall (24 h vs. baseline GMR 1.13; 95% CI 0.89–1.45; p = 0.305) and remained non-significant within both Group A (n = 10) and Group B (n = 11). Conclusions in adults ≥ 50 years, serum NfL neither distinguished anticipated VP-shunt responders with iNPH from surgical controls nor exhibited an acute change at 24 h after surgery start under general anesthesia. These findings suggest limited standalone diagnostic/prognostic utility of serum NfL in this setting. Interpretation should be age-aware and integrated with complementary clinical data and biomarkers; future studies should use standardized sampling and multimodal panels to refine risk stratification.